Only 26% are due to the inclusion of "please RT!" in the tweet.
Experts said the lack of published data on Russia’s vaccine - including how it is made and details on safety, immune response and whether it can prevent COVID-19 infection - leaves scientists, health authorities and the public in the dark. Read more: https://t.co/bmmUEQTNap 5/5 https://t.co/fuYIhO2oTh
Several drugmakers, including Moderna, Pfizer and AstraZeneca, say they hope to know if their vaccines work by the end of this year. All are expected to publish their trial results and safety data and submit them to regulators for scrutiny before being granted a license 4/5 https://t.co/T9JwRvUDfx
The Russian vaccine’s approval by the Health Ministry comes before trials that would normally involve thousands of participants, commonly known as a Phase III trial. Such trials are usually considered essential precursors for a vaccine to secure regulatory approval 3/5 https://t.co/wPwoR9SiDX
Many U.S. universities are revamping campuses to resume in-person classes despite COVID-19, requiring students to be tested, wear masks and socially distance, but some college town residents and critics say schools are putting profits before public safety https://t.co/VI4vcXPLDU
Scientists ask: Without trial data, how can we trust Russia's COVID vaccine? An announcement by the country that it will approve a COVID-19 vaccine after less than two months of human testing prompted alarm among global health experts https://t.co/bmmUEQTNap 1/5 https://t.co/fgS0UF2Y09
Young artists and activists in the Bay Area are combining social protest with performance. “I think that joy is a revolutionary emotion,” said one young dancer, “especially during these really hard apocalyptic times that we are living through.” https://t.co/rHzmQbBhlc